ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135371; 2) Community: the network communities that were significantly associated with the response to NSC 135371; 3) Molecule: the relationships between components within communities and NSC 135371; 4) MDR: the compounds that were significantly associated with the NSC 135371.

NSC Compound Enrichment Correlation
NSC 667088 Null 0.0135714101922724 0.50920905
NSC 668490 Null 0.0135714101922724 0.16528378
NSC 679516 Null 0.0135714101922724 0.43724977
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.0135714101922724 0.23990504
NSC 715407 Null 0.0135714101922724 0.51870979
NSC 725098 Null 0.0135714101922724 0.18930143
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0139796580235792 0.25673881
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0139796580235794 0.22967835
NSC 244404 Null 0.0139796580235794 0.22190221
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.0139796580235794 0.37701345
Total:87  Current:33    [First] [Prev] [Next] [Last]